Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells

While the delivery of small interfering RNAs (siRNAs) is an attractive strategy to treat several clinical con- ditions, siRNA-nanocarriers stability after intravenous administration is still a major obstacle for the development of RNA-interference based therapies. But, although the need for stabilit...

ver descrição completa

Detalhes bibliográficos
Autor principal: Oliveira, Ana Cristina Norberto Gonçalves (author)
Outros Autores: Raemdonck, Koen (author), Martens, Thomas (author), Rombouts, Koen (author), Simón-Vázquez, Rosana (author), Botelho, C. M. (author), Lopes, Ivo Edgar Araújo (author), Lúcio, M. (author), González-Fernández, África (author), Real Oliveira, M. Elisabete C.D. (author), Gomes, Andreia (author), Braeckmans, Kevin (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
FFS
fSPT
Monoolein
PEG
siRNA delivery
Ciências Médicas::Biotecnologia Médica
Science & Technology
Texto completo:http://hdl.handle.net/1822/37227
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/37227

Texto Completo

http://hdl.handle.net/1822/37227

Registos relacionados